Biospifar SA
Industry
- Distributors
- Pharmaceuticals
See more in Biomedtracker
Latest on Biospifar SA
In Vivo
• By Amanda Micklus
When a drug developer loses a partner, there's actually a 50-50 chance that the drug will remain in development, according to a new study of deals data from Informa’s Strategic Transactions . And of
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Grifols SA Novartis AG Novartis Vaccines & Diagnostics Inc. Grifols SA (plasma therapies) acquired the transfusion diagnostics business of Novartis AG